Author name: Wembrace

a mam stressing over prostate cancer

Prostate Cancer in India: A Silent Threat Gaining Ground

June marks Men’s Health Month, a crucial time to spotlight health issues that predominantly affect men. Among these, prostate cancer stands out as a growing concern in India. Often underdiagnosed and misunderstood, this disease is witnessing a steady rise in incidence across the country.  The Rising Tide: Prostate Cancer Statistics in India Globally, prostate cancer […]

Prostate Cancer in India: A Silent Threat Gaining Ground Read More »

Dermatitis Demystified: Understanding Causes, Symptoms, and Treatments"

“Dermatitis Demystified”

Dermatitis Demystified: Understanding Causes, Symptoms, and Treatments Skin, the body’s largest organ, often signals our overall health and well-being. One of the common skin conditions people across the globe experience is dermatitis. Although not life-threatening, dermatitis can cause significant discomfort and distress due to its inflammatory nature and visible symptoms. This blog aims to demystify

“Dermatitis Demystified” Read More »

Understanding bladder cancer

 “Understanding Bladder Cancer: Causes, Symptoms, and Treatment”

Understanding Bladder Cancer : Causes, Symptoms, and Treatment Bladder cancer, while not as widely discussed as other types of cancer, is a significant global health issue, ranking as the 10th most common cancer worldwide. Despite its prevalence, there is often a lack of public understanding and awareness about this disease. In this blog post, we

 “Understanding Bladder Cancer: Causes, Symptoms, and Treatment” Read More »

Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice

Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice Question: Are cancer patients receiving appropriate nutritional screening, assessment, and interventions? SUMMARY ANSWER: Cancer Nutrition plays a crucial role for patients with cancer; however, nutritional problems are often under-prioritised, underdiagnosed, and undertreated, thereby affecting treatment outcomes and quality of life WHAT

Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice Read More »

Personalise Cancer Medicine: An ESMO Guide for Patients

Personalised Cancer Medicine: An ESMO Guide for Patients Personalised cancer management – which means giving patients the optimum treatment according to their circumstances (including their genetics) and the molecular characteristics of their tumors – is a crucial theme of ESMO in 2013 What Is the Aim of Personalised Cancer Medicine The aim of personalised Cancer

Personalise Cancer Medicine: An ESMO Guide for Patients Read More »

Good Nutrition : The Fifth Pillar Of Cancer Treatment Good Nutrition

Good Nutrition: The Fifth Pillar Of Cancer Treatment Cancer occurs due to the uncontrolled growth of cells, which are the basic building blocks of the body. Receiving a cancer diagnosis is often a distressing experience, followed by significant pain, suffering, and heartbreak. Despite substantial advances in cancer research and management over the past few decades,

Good Nutrition : The Fifth Pillar Of Cancer Treatment Good Nutrition Read More »

Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population

Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination, however, real world evidence in the Indian patients

Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population Read More »

CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer

CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer CDK-4/6 inhibitors for the treatment of HR+/HER2 The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination. Hormone

CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer Read More »

Scroll to Top